BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1369 related articles for article (PubMed ID: 21459634)

  • 1. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.
    Monti JM
    Sleep Med Rev; 2010 Oct; 14(5):319-27. PubMed ID: 20153670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2014 Feb; 259():321-9. PubMed ID: 24286819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-HT(2A) receptor antagonists in the treatment of insomnia: present status and future prospects.
    Monti JM
    Drugs Today (Barc); 2010 Mar; 46(3):183-93. PubMed ID: 20467592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of dopamine in the modulation of sleep and waking.
    Monti JM; Monti D
    Sleep Med Rev; 2007 Apr; 11(2):113-33. PubMed ID: 17275369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness.
    Monti JM
    Sleep Med Rev; 2010 Oct; 14(5):307-17. PubMed ID: 20153669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
    Adrien J
    J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diltiazem potentiates pentobarbital-induced hypnosis via 5-HT1A and 5-HT2A/2C receptors: role for dorsal raphe nucleus.
    Cui SY; Cui XY; Zhang J; Wang ZJ; Yu B; Sheng ZF; Zhang XQ; Shi XL; Zhang YH
    Pharmacol Biochem Behav; 2011 Oct; 99(4):566-72. PubMed ID: 21689675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.
    Monti JM; Monti D
    Life Sci; 2000 Apr; 66(21):1999-2012. PubMed ID: 10823340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanin-concentrating hormone control of sleep-wake behavior.
    Monti JM; Torterolo P; Lagos P
    Sleep Med Rev; 2013 Aug; 17(4):293-8. PubMed ID: 23477948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Schechter LE
    Behav Brain Res; 2013 Jul; 249():65-74. PubMed ID: 23624323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
    Monti JM; Jantos H; Monti D; Alvariño F
    Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.